VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 93 filers reported holding VERVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,927,983 | -38.8% | 296,228 | -13.4% | 0.00% | -100.0% |
| Q2 2023 | $6,413,515 | +84.7% | 342,054 | +42.0% | 0.00% | – |
| Q1 2023 | $3,472,639 | +85.1% | 240,821 | +148.4% | 0.00% | – |
| Q4 2022 | $1,875,847 | -58.7% | 96,943 | -26.7% | 0.00% | -100.0% |
| Q3 2022 | $4,545,000 | +50.5% | 132,326 | -33.0% | 0.00% | – |
| Q2 2022 | $3,020,000 | -38.9% | 197,546 | -8.9% | 0.00% | -100.0% |
| Q1 2022 | $4,945,000 | +682.4% | 216,772 | +1163.5% | 0.00% | – |
| Q4 2021 | $632,000 | +129.0% | 17,156 | +191.3% | 0.00% | – |
| Q3 2021 | $276,000 | +85.2% | 5,889 | +138.6% | 0.00% | – |
| Q2 2021 | $149,000 | – | 2,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |